CS On Dr Reddy’s
O-P, TP Rs 3055
Launch Momentum Stays Strong In The US
Estimate FY19-22 EBITDA CAGR Of 22% & RoCE To Double To 22%
Stock Has Multiple Option Values From China Injectable Opportunity
Feedback
DRREDDY 
Reputation: 13,324 • Sep 18, 2019 12:48 PM
Vote
Comment
Share